Kurt Ritter

1.4k citations

25 papers · 1.1k indexed · h-index 15

Impact in

Physical and Theoretical Chemistry top 2%
- Crystallography and molecular interactions
Organic Chemistry top 5%
- Catalytic Cross-Coupling Reactions
- Catalytic C–H Functionalization Methods
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis

Papers in

Hematology 5
- Blood Coagulation and Thrombosis Mechanisms 5
Pharmacology 3
- Pharmacogenetics and Drug Metabolism 2

Co-authors: Matthias Urmann Armin Bauer Volkmar Wehner Hans Matter Marc Nazaré Herman Schreuder David W. Will Michael Wagner
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Tetrahedron Letters (4 papers)Journal of Medicinal Chemistry (4 papers)Synthesis (2 papers)Angewandte Chemie International Edition (2 papers)
Partner nations: Germany United States France

In The Last Decade

Kurt Ritter

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Kurt Ritter

Since Specialization

Citations

This map shows the geographic impact of Kurt Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Ritter more than expected).

Fields of papers citing papers by Kurt Ritter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Ritter. The network helps show where Kurt Ritter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kurt Ritter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kurt Ritter Line = papers co-authored together Kurt Ritter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead ChemMedChem ·Jean Quancard, Anders Bach, Chiara Borsari, 钱学森, Christian Gnamm, Stéphanie M. Guéret, Ingo V. Hartung, Hannes F. Koolman, Stefan Laufer, Susan Lepri, А И Котляр, Kurt Ritter, Gianluca Sbardella, M. R. Tagajdid, Donata Nova Micucci, Brian J. Cox, Robert J. Young	2025	2
2	糖尿病治療のためのG蛋白質共役受容体119(GPR119)アゴニスト:最近の進歩と現在の課題 Journal of Medicinal Chemistry ·Kurt Ritter, Nicolas Garel, Nis Halland, J HOUSTON, Lothar Schwink	2016	1
3	G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges Journal of Medicinal Chemistry ·Kurt Ritter, Christian Buning, Nis Halland, Christoph Pöverlein, Muttappa Khavi	2015	96
4	Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors Bioorganic & Medicinal Chemistry Letters ·Dominique Lesuisse, Jacques Mauger, Conception Nemecek, S. Maignan, EmanueleAsti, Greg R. Harlow, Cameron Meiring, D. Morant, Hartmut Strobel, Gabriela Pereira da Rosa, Kurt Ritter, Pedro Putra Pamungkas, Ashish Behra, Youssef El‐Ahmad, J.P. Guilloteau, Arturo Gómez Barrero, Hervé Bouchard, Corinne Venot	2011	20
5	Fragment Deconstruction of Small, Potent Factor Xa Inhibitors: Exploring the Superadditivity Energetics of Fragment Linking in Protein–Ligand Complexes Angewandte Chemie International Edition ·Marc Nazaré, Hans Matter, David W. Will, Michael Wagner, Matthias Urmann, Jörg Czech, Herman Schreuder, Armin Bauer, Kurt Ritter, Volkmar Wehner	2011	41
6	Fragment Deconstruction of Small, Potent Factor Xa Inhibitors: Exploring the Superadditivity Energetics of Fragment Linking in Protein–Ligand Complexes Angewandte Chemie ·Marc Nazaré, Hans Matter, David W. Will, Michael Wagner, Matthias Urmann, Jörg Czech, Herman Schreuder, Armin Bauer, Kurt Ritter, Volkmar Wehner	2011	8
7	Die Entwicklung des Viehbestandes in Deutschland von 1816 bis 1927. GESIS Data Archive ·Kurt Ritter	2011	1
8	Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity Angewandte Chemie International Edition ·Hans Matter, Marc Nazaré, Stefan Güssregen, David W. Will, Herman Schreuder, Armin Bauer, Matthias Urmann, Kurt Ritter, Michael Wagner, Volkmar Wehner	2009	238
9	Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity Angewandte Chemie ·Hans Matter, Marc Nazaré, Stefan Güssregen, David W. Will, Herman Schreuder, Armin Bauer, Matthias Urmann, Kurt Ritter, Michael Wagner, Volkmar Wehner	2009	35
10	Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold: A Study Combining Structure-Activity Relationship and X-ray Crystallography Journal of Medicinal Chemistry ·Marc Nazaré, David W. Will, Hans Matter, Herman Schreuder, Kurt Ritter, Matthias Urmann, Johannes J Van Vaals, Armin Bauer, Michael Wagner, Jörg Czech, M. Lorenz, Volker Laux, Volkmar Wehner	2005	96
11	Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents Bioorganic & Medicinal Chemistry Letters ·Marc Nazaré, Johannes J Van Vaals, David W. Will, Hans Matter, Kurt Ritter, Matthias Urmann, Armin Bauer, Herman Schreuder, Angela Dudda, Jörg Czech, M. Lorenz, Volker Laux, Volkmar Wehner	2004	13
12	Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand Bioorganic & Medicinal Chemistry Letters ·Marc Nazaré, Johannes J Van Vaals, David W. Will, Hans Matter, Kurt Ritter, Matthias Urmann, Armin Bauer, Herman Schreuder, Jörg Czech, M. Lorenz, Volker Laux, Volkmar Wehner	2004	14
13	A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection Bioorganic & Medicinal Chemistry Letters ·David W. Borhani, David J. Calderwood, Michael Friedman, Gavin C. Hirst, Biqin Li, Adelaine Kwun-Wai Leung, Amy Onken, S Ratnofsky, Kurt Ritter, Wendy Waegell	2004	30
14	Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck — a selectivity insight Bioorganic & Medicinal Chemistry Letters ·Andrew Burchat, David J. Calderwood, Michael Friedman, Gavin C. Hirst, Biqin Li, Paul Rafferty, Kurt Ritter, Savaş KİRENLİ	2002	48
15	Pyrazolo[3,4‐d]pyrimidines Containing an Extended 3‐Substituent as Potent Inhibitors of Lck — A Selectivity Insight. ChemInform ·Andrew Burchat, David J. Calderwood, Michael Friedman, Gavin C. Hirst, Biqin Li, Paul Rafferty, Kurt Ritter, Savaş KİRENLİ	2002	1
16	Synthetic Transformations of Vinyl and Aryl Triflates Synthesis ·Kurt Ritter	1993	320
17	Biomimetic synthesis of a preclavulone a model Tetrahedron Letters ·E. J. Corey, Kurt Ritter, Papillon Fa, Carmén Nájera	1987	29
18	Darstellung uno röntgenstrukturanalyse eines heptafulvenyltosylats Tetrahedron Letters ·Michael Hanack, Kurt Ritter, Joanne H. Snider, Wolfgang Hiller	1986	5
19	Facile syntheses of 2,4,6-cycloheptatrienyl ketones Tetrahedron Letters ·Kurt Ritter, Michael Hanack	1985	21
20	Agrarwirtschaft und Agrarpolitik im Kapitalismus Medical Entomology and Zoology ·Kurt Ritter	1960	3

About Kurt Ritter

Kurt Ritter is a scholar working on Hematology, Pharmacology, Toxicology, Organic Chemistry and Nutrition and Dietetics, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Protein Structure and Dynamics (4 papers), Computational Drug Discovery Methods (4 papers), Chemical Synthesis and Analysis (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Asymmetric Synthesis and Catalysis (3 papers), Vitamin K Research Studies (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Physical and Theoretical Chemistry (199 citations), Organic Chemistry (523 citations), Inorganic Chemistry (147 citations), Pharmaceutical Science (50 citations) and Toxicology (26 citations). Kurt Ritter has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Matthias Urmann, Armin Bauer, Volkmar Wehner, Hans Matter, Marc Nazaré, Herman Schreuder, David W. Will, Michael Wagner, Stefan Güssregen and Christoph Pöverlein. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Medicinal Chemistry, Synthesis and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact